Search results (1331)
« Back to PublicationsClinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.
Parkes EE. and Kennedy RD., (2016), Oncologist, 21, 586 - 593
PREFERENCE-BASED UTILITIES FOR ADJUVANT MELANOMA IN THE UNITED KINGDOM AND AUSTRALIA
Middleton M. et al, (2016), VALUE IN HEALTH, 19, A157 - A157
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma.
Eyre TA. et al, (2016), Br J Haematol, 173, 487 - 491
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma
Eyre TA. et al, (2016), BRITISH JOURNAL OF HAEMATOLOGY, 173, 487 - 491
TREATMENT PATTERNS AMONG ADVANCED MELANOMA PATIENTS IN EUROPE
Sheahan K. et al, (2016), VALUE IN HEALTH, 19, A162 - A162
Durable response of spinal chordoma to combined inhibition of IGF-1R and EGFR
Macaulay V. et al, (2016), Frontiers in Oncology
A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.
Buckley NE. et al, (2016), Oncotarget, 7, 19884 - 19896
Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways
Psaila B. et al, (2016), Genome Biology
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy.
Findlay JM. et al, (2016), Nature communications, 7, 11111 - 11111
Single cell RNA sequencing reveals molecular and functional platelet bias of aged hematopoietic stem cells
Nerlov C. et al, (2016), Nature Communications
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.
Hopkins TG. et al, (2016), Nucleic Acids Res, 44, 1227 - 1246
Phase I Dose Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Macaulay V., (2016), Clinical Cancer Research
A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors
Buono M. et al, (2016), Nature Cell Biology
A phase Ib study of NUC1031 and carboplatin for patients with recurrent ovarian cancer.
Blagden SP. et al, (2016), JOURNAL OF CLINICAL ONCOLOGY, 34
Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality.
Lord S. et al, (2016), Curr Drug Targets, 17, 1714 - 1727
Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.
Findlay JM. et al, (2016), Dig Dis Sci, 61, 25 - 38
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials.
Malczewski A. et al, (2016), Cancer Med, 5, 17 - 23
SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer
Kumar S. et al, (2016), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 26, 832 - 833